Sommaire

Numéro précédent | Numéro suivant

• • ·The International Union Against Tuberculosis and Lung Disease model National Tuberculosis Programmes

    Page :95-99

    D.A. Enarson

    
• • ·Trend of initial drug resistance of tubercle bacilli isolated from new patients with pulmonary tuberculosis and its correlation with the tuberculosis programme in Beijing

    Page :100-103

    L.X. Zhang, G.Q. Kan, D.H. Tu, J.S. Li, X.X. Liu

    Résumé Résumé
• • ·Treatment of pulmonary disease caused by Mycobacterium kansasii: Results of 18 vs 12 months' chemotherapy

    Page :104-108

    J. Sauret, S. Hernández-Flix, E. Castro, L. Hernández, V. Ausina, P. Coll

    Résumé Résumé
• • ·Study of the effect of concomitant food on the bioavailability of rifampicin, isoniazid and pyrazinamide

    Page :109-113

    C. Zent, P. Smith

    Résumé Résumé
• • ·Methodological issues in the estimation of the tuberculosis problem from tuberculin surveys

    Page :114-121

    H.L. Rieder

    Résumé Résumé
• • ·Tuberculin sensitivity and the BCG scar in tuberculosis contacts

    Page :122-125

    H. Johnson, B. Lee, E. Doherty, E. Kelly, T. McDonnell

    Résumé Résumé
• • ·Tuberculin sensitivity trends in Hellenic army recruits during the period 1981-91

    Page :126-129

    D. Bouros, I. Demoiliopoulos, M. Moschos, P. Panagou, D. Demoiliopoulos, S. Konstantopoulos, N. Siafakas

    Résumé Résumé
• • ·Serum soluble interleukin-2 receptor: A useful indicator of the clinical course in pulmonary tuberculosis

    Page :130-135

    M.J.Avilés Inglés, C. Contessotto, J.Ontañón Rodriguez, A.García Alonso, M.Muro Amador, M.Canteras Jordana, F.Sánchez Gascón, R.Alvarez López

    Résumé Résumé
• • ·In vitro activities of 2,2′-bipyridyl analogues against Mycobacterium avium and M. tuberculosis

    Page :136-140

    A.M. Dhople, A.A. Dhople, M.A. Ibanez

    Résumé Résumé
• • ·Distribution and characterization of β-lactamases of mycobacteria and related organisms

    Page :141-148

    H.H. Kwon, H. Tomioka, H. Saito

    Résumé Résumé
• • ·Humoral response to Mycobacterium tuberculosis-specific antigens in African tuberculosis patients with high prevalence of Human immunodeficiency virus infection

    Page :149-155

    S. Thybo, C. Richter, H. Wachmann, S.Y. Maselle, D.H. Mwakyusa, I. Mtoni, Å.B. Andersen

    Résumé Résumé
• • ·Tracing as part of tuberculosis control in a rural Cambodian district during 1992

    Page :156-159

    M.E. Kimerling, L. Petri

    Résumé Résumé
• • ·Isolation of Mycobacterium malmoense from the environment in Zaire

    Page :160-162

    F. Portaels, L. Larsson, P.A. Jenkins

    Résumé Résumé
• • ·Isolation of Mycobacterium chelonae in a bronchoscopy unit and its subsequent eradication

    Page :163-167

    J.L. Kiely, S. Sheehan, B. Cryan, C.P. Bredin

    Résumé Résumé
• • ·Disseminated Mycobacterium genavense infection in Canadian AIDS patients

    Page :168-170

    S.D. Shafran, G.D. Taylor, J.A. Talbot

    Résumé Résumé
• • ·Mycobacterium malmoense in Italy

    Page :171-172

    C. Piersimoni, L. Felici, V. Penati, C. Lacchini

    Résumé Résumé
• • ·Ciprofloxacin-induced renal dysfunction in patients with mycobacterial lung infections

    Page :173-175

    W.W. Yew, C.H. Chau, P.C. Wong, H.Y. Choi

    Résumé Résumé
• • ·Oral tuberculosis: Primary localisation in an elderly non-immunodepressed patient

    Page :176-177

    A. Antico

    Résumé Résumé
• • ·An unusual presentation: Primary tuberculosis of the middle ear cleft

    Page :178-179

    T. Ozcelik, M. Ataman, G. Gedikoglu

    Résumé Résumé
• • ·Compliance with tuberculosis treatment in a rural district

    Page :180

    David Wilkinson

    
• • ·Hypersensitivity to multiple drugs streptomycin, rifampicin and ethambutol: An unusual presentation

    Page :181

    Tilak Dhamgaye, K.C. Mohanty